FDG PET in the Evaluation of Treatment for Lymphoma: Clinical Usefulness and Pitfalls

This publication has 32 references indexed in Scilit:

• Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation
  Blood, 2003
• Utility of FDG-PET scanning in lymphoma by WHO classification
  Blood, 2003
• Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation
  Leukemia, 2002
• Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
  Blood, 2001
• Benign causes of 18-FDG uptake on whole body imaging
  Seminars in Nuclear Medicine, 1998
• Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors
  Cancer, 1998
• Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Diffusely Increased Colonic F-18 FDG Uptake in Acute Enterocolitis
  Clinical Nuclear Medicine, 1995
• Increased F-18 FDG Accumulation in an Acute Fracture
  Clinical Nuclear Medicine, 1994
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993